Creative Medical Technology Holdings, Inc. (CELZ)
0.623
+0.02
(+2.81%)
USD |
NASDAQ |
Nov 06, 10:31
Creative Medical Technology Holdings EPS Diluted (Quarterly) : -0.4085 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4085 |
| March 31, 2026 | -0.3796 |
| December 31, 2025 | -0.5106 |
| September 30, 2025 | -0.479 |
| June 30, 2025 | -0.4779 |
| March 31, 2025 | -0.827 |
| December 31, 2024 | -1.123 |
| September 30, 2024 | -0.7471 |
| June 30, 2024 | -1.108 |
| March 31, 2024 | -0.7327 |
| December 31, 2023 | -1.208 |
| September 30, 2023 | -1.016 |
| June 30, 2023 | -0.7817 |
| March 31, 2023 | -0.7473 |
| December 31, 2022 | -4.416 |
| September 30, 2022 | -0.6983 |
| June 30, 2022 | -1.988 |
| March 31, 2022 | -1.789 |
| December 31, 2021 | -7.675 |
| September 30, 2021 | -7.50 |
| June 30, 2021 | -12.50 |
| March 31, 2021 | 111.85 |
| December 31, 2020 | -251.25 |
| September 30, 2020 | 1.45 |
| June 30, 2020 | -54.45 |
| Date | Value |
|---|---|
| March 31, 2020 | 24.10 |
| December 31, 2019 | -1155.00 |
| September 30, 2019 | -1192.50 |
| June 30, 2019 | -60.00 |
| March 31, 2019 | -622.50 |
| December 31, 2018 | 1605.00 |
| September 30, 2018 | -1597.50 |
| June 30, 2018 | -7500.00 |
| March 31, 2018 | -30000.00 |
| December 31, 2017 | -9652.50 |
| September 30, 2017 | -367.50 |
| June 30, 2017 | -7500.00 |
| March 31, 2017 | -1740.00 |
| December 31, 2016 | -1387.50 |
| September 30, 2016 | -1597.50 |
| June 30, 2016 | -1590.00 |
| March 31, 2016 | -210.00 |
| December 31, 2015 | -367.50 |
| September 30, 2015 | -262.50 |
| June 30, 2015 | -262.50 |
| March 31, 2015 | -382.50 |
| December 31, 2014 | -270.00 |
| September 30, 2014 | -240.00 |
| June 30, 2014 | -240.00 |
| March 31, 2014 | -412.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.511M |
| Total Expenses (Quarterly) | 1.512M |
| Enterprise Value | -4.881M |
| Earnings Yield | -285.3% |
| Normalized Earnings Yield | -285.33 |